CNMD CONMED Corp

Price (delayed)

$72.84

Market cap

$2.24B

P/E Ratio

27.08

Dividend/share

$0.8

EPS

$2.69

Enterprise value

$3.2B

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, ...

Highlights
The net income has soared by 188% year-on-year and by 28% since the previous quarter
CNMD's EPS has soared by 185% YoY and by 28% QoQ

Key stats

What are the main financial stats of CNMD
Market
Shares outstanding
30.8M
Market cap
$2.24B
Enterprise value
$3.2B
Valuations
Price to book (P/B)
2.62
Price to sales (P/S)
1.78
EV/EBIT
22.39
EV/EBITDA
20.12
EV/Sales
2.54
Earnings
Revenue
$1.26B
EBIT
$142.92M
EBITDA
$159.11M
Free cash flow
$141.5M
Per share
EPS
$2.69
Free cash flow per share
$4.6
Book value per share
$27.77
Revenue per share
$40.99
TBVPS
$27.99
Balance sheet
Total assets
$2.31B
Total liabilities
$1.45B
Debt
$990.8M
Equity
$854.66M
Working capital
$344.32M
Liquidity
Debt to equity
1.16
Current ratio
2.18
Quick ratio
0.94
Net debt/EBITDA
6.01
Margins
EBITDA margin
12.6%
Gross margin
54.9%
Net margin
6.5%
Operating margin
11.3%
Efficiency
Return on assets
3.6%
Return on equity
10.1%
Return on invested capital
9.6%
Return on capital employed
7.1%
Return on sales
11.3%
Dividend
Dividend yield
1.1%
DPS
$0.8
Payout ratio
29.7%

CNMD stock price

How has the CONMED stock price performed over time
Intraday
1.73%
1 week
1.75%
1 month
8.85%
1 year
-39.37%
YTD
-33.49%
QTD
5.08%

Financial performance

How have CONMED's revenue and profit performed over time
Revenue
$1.26B
Gross profit
$692.89M
Operating income
$142.92M
Net income
$82.35M
Gross margin
54.9%
Net margin
6.5%
The net income has soared by 188% year-on-year and by 28% since the previous quarter
The company's net margin has surged by 176% YoY and by 25% QoQ
The operating income has increased by 19% since the previous quarter
CONMED's gross profit has increased by 17% YoY and by 2.5% QoQ

Growth

What is CONMED's growth rate over time

Valuation

What is CONMED stock price valuation
P/E
27.08
P/B
2.62
P/S
1.78
EV/EBIT
22.39
EV/EBITDA
20.12
EV/Sales
2.54
CNMD's EPS has soared by 185% YoY and by 28% QoQ
The stock's price to earnings (P/E) is 41% less than its last 4 quarters average of 45.1
The stock's price to book (P/B) is 39% less than its 5-year quarterly average of 4.2 and 36% less than its last 4 quarters average of 4.0
CNMD's equity is up by 14% YoY and by 2.5% from the previous quarter
CNMD's P/S is 44% less than its 5-year quarterly average of 3.1 and 35% less than its last 4 quarters average of 2.7
CNMD's revenue is up by 15% year-on-year

Efficiency

How efficient is CONMED business performance
CNMD's return on assets has surged by 186% year-on-year and by 29% since the previous quarter
The ROE has soared by 178% YoY and by 23% from the previous quarter
CNMD's return on invested capital is up by 19% since the previous quarter
CNMD's ROS is up by 16% QoQ

Dividends

What is CNMD's dividend history
DPS
$0.8
Dividend yield
1.1%
Payout ratio
29.7%
Recent dividends

Financial health

How did CONMED financials performed over time
CNMD's total assets is 59% greater than its total liabilities
CNMD's quick ratio is up by 25% YoY and by 9% QoQ
The current ratio has grown by 15% YoY and by 10% from the previous quarter
The company's debt is 16% higher than its equity
The company's debt to equity fell by 18% YoY
CNMD's equity is up by 14% YoY and by 2.5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.